pharmaceutical care to hypertensive patients by - Unifal-MG

advertisement
PHARMACEUTICAL
PHARMACY
CARE
TO
HYPERTENSIVE
PATIENTS
BY
COMMUNITY
VITOR LIMA ESQUERDO1, AMILTON MARQUES2, LUCIENE ALVES MOREIRA MARQUES1
1
Universidade Federal de Alfenas, UNIFAL-MG; 2 Centro Universitário de Lavras, UNILAVRAS
The arterial hypertension, main factor of death risk among the non transmissible diseases is an important
problem of public health. The objective of the research was to supply the service of Pharmaceutical care
and pharmacotherapeutic follow-up to hypertensive patients, users of the Public Pharmacy in Carlos
Chagas, MG, Brazil and to evaluate if the pharmaceutical care contributes to the control of the blood
pressure. The pharmacotherapeutic follow-up profile of 64 hypertensive patients of both sexes was
accomplished. They were chosen in a random manner, with 8 patients to participate in the
pharmacotherapeutic follow-up. The methodology used was the method Dáder of pharmacotherapeutic
follow up. The data were analyzed by the test non parametric of Wilcoxon at the level of significance of
5%. Of the 64 patients, 39.06% are males and 60.94% females. Approximately 36% are not educated,
56.25% have basic education, 6.25% have medium level education and 1.56% higher education. In
agreement with “V Diretrizes Brasileira de Hipertensão Arterial”, 39% showed normal pressure, 17%
bordering, 23% hypertension level 1, 7% hypertension level 2 and 14% hypertension level 3. The
medicines mostly used were hydrochlorothiazide 25 mg (64.06%) and captopril 25 mg (45.31%). In
relation to the average systolic pressure medium of the group in pharmacotherapeutic follow-up, there
was a reduction of 18.37 mmHg (153.12 to 134.75 mmHg) not significant (p=0.0587). In relation to the
average diastolic pressure of the group, there was a reduction of 13.5 mmHg (92 for 78.5 mmHg),
significant at level 5% (p=0.0357). One of the limitations of the study was the number of patients who
stuck to the accompaniment and perhaps that justifies the non significant reduction in the systolic blood
pressure. These results were suitable, when compared with other studies. The pharmaceutical care was
effective in controlling the blood pressure of the studied group.
PHARMACEUTICAL CARE AND COMPLEMENTARY AND ALTERNATIVE MEDICINE IN
SUS: KNOWLEDGE AND ACCEPTANCE OF THE HEALTH USERS
FLAVIA VANESSA VIEIRA RIBEIRO DO VALE1, VALÉRIA APARECIDA DOS SANTOS
NOGUEIRA2, FÁBIO LUIZ MIALHE2, LUCIENE ALVES MOREIRA MARQUES1
1
Universidade Federal de Alfenas, UNIFAL-MG; 2 Universidade Estadual de Campinas, FOP-UNICAMP
In 2006, the Ministry of Health created the national politics of complementary and alternative medicine in
SUS. The objective of the present study was to investigate the knowledge and the acceptance of the
complementary and alternative medicine and pharmaceutical care of a sample of SUS users and health
professionals. It was conducted a cross-sectional descriptive qualitative and quantitative study in
Pharmacy located in a Basic Unit of Health in the city of São João da Mata, Minas Gerais, Brazil with
three doctors and thirty-five service users. It was verified that all patients didn’t know what were the
complementary and alternative medicines. After the researcher’s explanation about the topic, 31.42% of
users said that they would accept the use herbal medicine or phytotherapy, 51.42% would accept to use
acupuncture, 37.14% would accept homeopathy and none would accept the crenotherapy. When they
were investigated about the pharmaceutical care, 45.71% said that they had already heard about this
subject, 22.85% know the term and 31.42% never heard anything about pharmaceutical care. When
interviewing the three doctors that assist in the unit of health, it was observed indifference, acceptance
and rejection respectively. In conclusion, this research demonstrates that the great majority of those
researched would accept the use of complementary and alternative medicines if this was offered by the
unit of health. Besides, the users find it important to have a greater performance of the pharmacist. It is
necessary to implement popularization programs for patients and mainly for the doctors who prescribe
such practices.
Download